Has David Wells-Roth, MD received payments from drug or device companies?

Yes. Drug and device makers reported $40,196 in general payments to David Wells-Roth, MD across 95 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Wells-Roth, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Wells-Roth, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Wells-Roth, MD

Neurological Surgery · Edison, NJNPI 1366576845

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $28,718 of the $40,196 with a category attached, or 71.4%. Surgentec accounts for 72.7% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2024 at $32,945 and has fallen 88.0% since, to $3,950 in 2025.

$40,196in general payments, 2019–2025

Across 95 payments — averaging $423.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Surgentec$29K
4web, Inc.$5K
Expanding Innovations, Inc.$2K
Ecential Robotics$799
Nevro Corp.$518
Augmedics Inc.$350
plus $2K from 27 others

$2,399in ownership & investment interests, 2019–2025

Across 1 payment — averaging $2398.50 each. An ownership or investment interest held by the physician or an immediate family member.

Expanding Innovations, Inc.$2K

What the payments were for

Royalty or licence$28,71871%
Consulting fees$5,89915%
Travel & lodging$2731%
Food & beverage$5,30513%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Surgentec	2	$29,218
4web, Inc.	20	$4,852
Expanding Innovations, Inc.	2	$2,399
Ecential Robotics	2	$799
Nevro Corp.	12	$518
Augmedics Inc.	3	$350
Boston Scientific	2	$260
Providence Medical Technology, Inc.	4	$247
Stryker	5	$225
Ulrich Medical USA, Inc.	2	$191
Medtronic(2 entities)	6	$161
Globus Medical	2	$121
Zimvie Inc.	2	$118
Collegium Pharmaceutical, Inc.	6	$101
Zimmer Biomet	2	$96
DJO, LLC	2	$89
Smith+Nephew	1	$46
Choice Spine, LLC	1	$45
Abbott	2	$36
Vertos Medical, Inc.	2	$35
Protega Pharmaceutials Inc	2	$32
Foundation Fusion Solutions, LLC	2	$32
Relievant Medsystems, Inc.	1	$29
Ossdsign USA Incorporated	1	$28
Intrinsic Therapeutics	1	$25
Nalu Medical, Inc.	1	$21
Saluda Medical Americas, Inc.	1	$20
Johnson & Johnson	1	$19
EBI, LLC	1	$19
Highridge Medical LLC	1	$19
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$18
Vertex	1	$16
Portola Pharmaceuticals, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,196 in reported general payments places this provider in the 85th percentile of 174 neurological surgery providers in New Jersey.

See all neurological surgery providers in New Jersey →

Medicare billing

Part B allowed, 2024

$178,401

Medicare patients

116

Services billed

415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	21	$151
Oxycodone Hcl	15	$115
Methylprednisolone	18	$87
Tramadol Hcl	11	$24

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Edison

Vanessa MilanoEdison$17K
Aria JamshidiEdison$11K
Robert HearyNewark$1M
Harshpal SinghHackensack$677K
Ira GoldsteinMontclair$344K
Karthik MadhavanCherry Hill$291K
Simon SalernoWall Township$275K
Shabbar DanishNeptune$267K
Adam LipsonUnion$187K
Mohammed KhanOradell$178K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →